Hmm, Frankly speaking, there will not be enough shares to go around when human trials start, any day now, RDGL, is looking to up list , and they are right on track with the current share structure
I have to agree with you. I picked up a few at .013 and flipped them for a small profit. I like the concpt here but any time you are waiting on the FDA for anything, it takes way longer than anticipated in most cases. I plan to keep an eye on this one and look to buy back in 6 months or so after those 625 mill shares hit the market.
News 
Market Data 
Discover 
